Terms: = Prostate cancer AND NUTM1, NUT, 256646, ENSG00000184507 AND Treatment
2 results:
1. Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study.
Cousin S; Blay JY; Garcia IB; de Bono JS; Le Tourneau C; Moreno V; Trigo J; Hann CL; Azad AA; Im SA; Cassier PA; French CA; Italiano A; Keedy VL; Plummer R; Sablin MP; Hemming ML; Ferron-Brady G; Wyce A; Khaled A; Datta A; Foley SW; McCabe MT; Wu Y; Horner T; Kremer BE; Dhar A; O'Dwyer PJ; Shapiro GI; Piha-Paul SA
Int J Cancer; 2022 Mar; 150(6):993-1006. PubMed ID: 34724226
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological and Preclinical Findings of nut Carcinoma: A Multicenter Study.
Jung M; Kim S; Lee JK; Yoon SO; Park HS; Hong SW; Park WS; Kim JE; Kim J; Keam B; Kim HJ; Kang HJ; Kim DW; Jung KC; Kim YT; Heo DS; Kim TM; Jeon YK
Oncologist; 2019 Aug; 24(8):e740-e748. PubMed ID: 30696721
[TBL] [Abstract] [Full Text] [Related]
